FDA Inspection 1100047 — Amphastar Pharmaceuticals, Inc.
The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on Jul 25, 2019 in Rancho Cucamonga, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rancho Cucamonga, CA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)